About us

Our research focuses on diabetes precision diagnostics and management. We interrogate genetic data across the spectrum from rare to common variation to identify novel diabetes genes, subtypes, and mechanisms of disease. Of particular interest is identifying molecular subtypes of type 2 diabetes in order to improve patient care. Our research involves analyzing large-scale patient genomic data including from the UK Biobank, the Mass General Brigham Biobank, the Type 2 Diabetes Knowledge Portal, and many other collaborations. We are also involved in identifying patients with atypical diabetes though the Rare and Atypical Diabetes Network (RADIANT) study, where we lead patient recruitment at MGH. We work closely with the Florez Lab in a vibrant and collaborative environment at Mass General Hospital and the Broad Institute.

We also see patients with genetic forms of diabetes in the MGH Diabetes Genetics Clinic.